In contrast with these reports, we and others (Jacob et al, 2001; Magrini et al, 2002) have demonstrated higher sensitivity to CPT-11 in MMR-deficient human CRC cell lines than in MMR-proficient cells and G2/M arrest after exposure to CPT-11. Here, MRC1 is linked to colorectal carcinoma.